Comparison between dexmedetomidine and esketamine in pediatric dentistry surgery

被引:30
作者
Xin, Naixing [1 ]
Xu, Heng [1 ]
Yue, Chengjin [1 ]
机构
[1] Maternal & Child Hlth Hosp Hubei Prov, Dept Anesthesiol, 745 Wuluo Rd, Wuhan 430070, Peoples R China
关键词
Dexmedetomidine (D); esketamine (K); moderate sedation; pediatric dentistry; ORAL KETAMINE; INTRANASAL DEXMEDETOMIDINE; PROCEDURAL SEDATION; TRIPLE-BLIND; PREMEDICATION; MIDAZOLAM; CHILDREN; DELIRIUM; ANXIETY;
D O I
10.21037/tp-21-435
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Dexmedetomidine (D) and esketamine (K) are used for the sedation of pediatric dental surgery. This study was designed to compare the effect of intranasal D and K in producing moderate sedation for uncooperative pediatric dental patients. Methods: This prospective single-center cohort study was conducted at the Maternal and Child Health Hospital of Hubei Province after approval of the Medical Ethics Committee. One hundred and fifty American Society of Anesthesiologists (ASA) grade I and II patients aged 3-10 years who were uncooperative and could not be managed by conventional behavior management techniques were included in this study. Patients were classified into four groups. Group K was administered with esketamine (0.5 mg/kg), and group D was given D1 (1 mu g/kg), D2 (1.5 mu g/kg), or D3 (2.0 mu g/kg) intranasally. The outcome measurements included the sedation level, changes in vital signs, sedation onset and recovery times, analgesia, behavior, and overall success. Results: The sedation onset time was significantly shorter for K and D3 compared with D1 and D2. The recovery time was fastest in group D1. The overall success rate was highest in group D3, followed by the D2, D1, and K groups; however, the difference between them was not significant. The intra-and postoperative pain scores in the D3 and K groups were significantly lower than those in the D1 group. Conclusions: Intranasal D and K are effective in producing moderate sedation for uncooperative pediatric dental patients.
引用
收藏
页码:3159 / 3165
页数:7
相关论文
共 25 条
[1]   Bioavailability of dexmedetomidine after extravascular doses in healthy subjects [J].
Anttila, M ;
Penttilä, J ;
Helminen, A ;
Vuorilehto, L ;
Scheinin, H .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (06) :691-693
[2]   Analgesic and sedative effects of intranasal dexmedetomidine in third molar surgery under local anaesthesia [J].
Cheung, C. W. ;
Ng, K. F. J. ;
Liu, J. ;
Yuen, M. Y. V. ;
Ho, M. H. A. ;
Irwin, M. G. .
BRITISH JOURNAL OF ANAESTHESIA, 2011, 107 (03) :430-437
[3]   Oral ketamine-midazolam premedication of uncooperative patients in major outpatient surgery [J].
Cortinas, M. ;
Oya, B. ;
Caparros, P. ;
Cano, G. ;
Ibarra, M. ;
Martinez, L. .
REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2010, 57 (08) :479-485
[4]   Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials [J].
Duan, X. ;
Coburn, M. ;
Rossaint, R. ;
Sanders, R. D. ;
Waesberghe, J. V. ;
Kowark, A. .
BRITISH JOURNAL OF ANAESTHESIA, 2018, 121 (02) :384-397
[5]   Evaluation of intranasal midazolam in children undergoing esophagogastroduodenoscopy [J].
Fishbein, M ;
Lugo, RA ;
Woodland, J ;
Lininger, B ;
Linscheid, T .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1997, 25 (03) :261-266
[6]  
FLAITZ C M, 1985, Pediatric Dentistry, V7, P292
[7]  
Ghasemi Mahshid, 2018, Anesth Pain Med, V8, pe63230, DOI 10.5812/aapm.63230
[8]  
Green SM, 2000, ANN EMERG MED, V36, P480, DOI 10.1067/mem.2000.111426
[9]   THE ANALGESIC ACTION OF DEXMEDETOMIDINE - A NOVEL ALPHA-2-ADRENOCEPTOR AGONIST - IN HEALTHY-VOLUNTEERS [J].
JAAKOLA, ML ;
SALONEN, M ;
LEHTINEN, R ;
SCHEININ, H .
PAIN, 1991, 46 (03) :281-285
[10]   Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors [J].
Kain, ZN ;
Caldwell-Andrews, AA ;
Maranets, I ;
McClain, B ;
Gaal, D ;
Mayes, LC ;
Feng, R ;
Zhang, HP .
ANESTHESIA AND ANALGESIA, 2004, 99 (06) :1648-1654